Vaziri, S A <br/><br/>
Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.  [electronic resource] 

 -  Pharmacogenetics  Feb 2001 
 - 7-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-314X 
<br/><br/><label>Standard No.: </label>10.1097/00008571-200102000-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetyltransferases--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arylamine N-Acetyltransferase--genetics<br/>Biotransformation<br/>Carcinogens--metabolism<br/>Carcinoma, Transitional Cell--enzymology<br/>Cytochrome P-450 CYP1A2--metabolism<br/>Enzyme Activation<br/>Female<br/>Genotype<br/>Humans<br/>Isoenzymes<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Predictive Value of Tests<br/>Urinary Bladder Neoplasms--enzymology<br/>Urothelium--enzymology